MUMBAI, India, Sept. 22 -- Intellectual Property India has published a patent application (202621092284 A) filed by Symbiosis International Deemed University on July 29, 2026, for Ai-Driven Intelligent Oncology Platform For Integrated Cancer Care.
Inventors include Mr. Husain Nadaf; and Dr. Mangesh Jabade.
The application for the patent was published on September 18, 2026, under issue no. 38/2026.
Abstract: ABSTRACT AI-DRIVEN INTELLIGENT ONCOLOGY PLATFORM FOR INTEGRATED CANCER CARE An AI-driven intelligent oncology platform (100) for precision cancer care integrates a genomic analysis and mutation prediction module (110), a medical imaging and cancer diagnosis module (120), a digital twin simulation engine (130), a drug discovery and nanomedicine module (140), an immunotherapy optimization module (150), and a patient monitoring and oncology nursing module (160) through a central data integration and processing unit (180). The platform processes multi-modal patient data to identify oncogenic mutations, predict tumor evolution, detect cancerous lesions, simulate personalized treatment scenarios through digital twin models, accelerate drug discovery, optimize immunotherapy selection, and provide continuous AI-powered patient monitoring. A clinical decision support interface (170) presents integrated outputs, and an explainable AI reporting engine (190) ensures transparent clinical recommendations. The platform enables end-to-end AI-driven cancer management within a single unified architecture. [
Disclaimer: Curated by HT Syndication.
